Brilinta® (ticagrelor)
for Coronary Artery Disease

Brilinta (ticagrelor) is an antiplatelet medication that reduces the risk of heart attack, stroke, and death by preventing blood clots. It is used for individuals with a history of blocked arteries, prior heart attacks, coronary artery disease with stents, or reduced heart blood flow. It also lowers stroke risk in adults with arterial blockages affecting brain circulation.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Coronary Artery Disease - CAD